Follow the people · Insider
Amir Weiss
Amir Weiss files insider transactions with the SEC as a chief accounting officer of Teva Pharmaceutical Industries (TEVA). We hold 2 disclosed purchases and sales filed since 2 March 2022, 1 of them in the last 90 days.
- Files forTEVA
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure25 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 28 February 2022 — 21 August 2026Chief Accounting Officer · Teva Pharmaceutical Industries (TEVA)65 Form 4 lines · source: SEC Form 4
Everything they disclosed
65 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 6,945 shares of Teva Pharmaceutical IndustriesSEC Form 425 August 2026Ordinary Shares · traded 21 August 2026 · filed 25 August 2026
- exercised options over 2,500 shares of Teva Pharmaceutical IndustriesSEC Form 425 August 2026Ordinary Shares · traded 21 August 2026 · filed 25 August 2026
- ▼ sold on the open market 2,500 shares of Teva Pharmaceutical IndustriesSEC Form 425 August 2026Ordinary Shares · traded 21 August 2026 · filed 25 August 2026
- exercised options over 2,500 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 425 August 2026Stock Options (right to buy) · traded 21 August 2026 · filed 25 August 2026
- ▼ sold on the open market 10,679 shares of Teva Pharmaceutical IndustriesSEC Form 47 May 2026Ordinary Shares · traded 6 May 2026 · filed 7 May 2026
- exercised options over 3,537 shares of Teva Pharmaceutical IndustriesSEC Form 49 March 2026Ordinary Shares · traded 5 March 2026 · filed 9 March 2026
- exercised options over 3,537 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 49 March 2026Restricted Share Units · traded 5 March 2026 · filed 9 March 2026
- exercised options over 3,537 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 49 March 2026Restricted Share Units · traded 5 March 2026 · filed 9 March 2026
- exercised options over 3,537 shares of Teva Pharmaceutical IndustriesSEC Form 49 March 2026Ordinary Shares · traded 5 March 2026 · filed 9 March 2026
- exercised options over 10,679 shares of Teva Pharmaceutical IndustriesSEC Form 46 March 2026Ordinary Shares · traded 4 March 2026 · filed 6 March 2026
- exercised options over 5,650 shares of Teva Pharmaceutical IndustriesSEC Form 46 March 2026Ordinary Shares · traded 4 March 2026 · filed 6 March 2026
- exercised options over 10,679 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2026Restricted Share Units · traded 4 March 2026 · filed 6 March 2026
- exercised options over 10,679 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2026Restricted Share Units · traded 4 March 2026 · filed 6 March 2026
- exercised options over 5,650 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2026Restricted Share Units · traded 4 March 2026 · filed 6 March 2026
- was granted 11,280 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2026Restricted Share Units · traded 4 March 2026 · filed 6 March 2026
- exercised options over 5,650 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2026Restricted Share Units · traded 4 March 2026 · filed 6 March 2026
- was granted 11,280 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2026Restricted Share Units · traded 4 March 2026 · filed 6 March 2026
- exercised options over 10,679 shares of Teva Pharmaceutical IndustriesSEC Form 46 March 2026Ordinary Shares · traded 4 March 2026 · filed 6 March 2026
- exercised options over 5,650 shares of Teva Pharmaceutical IndustriesSEC Form 46 March 2026Ordinary Shares · traded 4 March 2026 · filed 6 March 2026
- exercised options over 5,179 shares of Teva Pharmaceutical IndustriesSEC Form 45 March 2026Ordinary Shares · traded 3 March 2026 · filed 5 March 2026
- exercised options over 5,179 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 45 March 2026Restricted Share Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 5,179 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 45 March 2026Restricted Share Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 5,179 shares of Teva Pharmaceutical IndustriesSEC Form 45 March 2026Ordinary Shares · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 12,300 shares of Teva Pharmaceutical IndustriesSEC Form 418 December 2025Ordinary Shares · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 12,300 shares of Teva Pharmaceutical IndustriesSEC Form 410 November 2025Ordinary Shares · traded 6 November 2025 · filed 10 November 2025
- exercised options over 3,566 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 47 March 2025Restricted Share Units · traded 5 March 2025 · filed 7 March 2025
- was granted 14,150 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 47 March 2025Restricted Share Units · traded 5 March 2025 · filed 7 March 2025
- exercised options over 3,566 shares of Teva Pharmaceutical IndustriesSEC Form 47 March 2025Ordinary Shares · traded 5 March 2025 · filed 7 March 2025
- exercised options over 10,676 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2025Restricted Share Units · traded 4 March 2025 · filed 6 March 2025
- exercised options over 5,650 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 46 March 2025Restricted Share Units · traded 4 March 2025 · filed 6 March 2025
- exercised options over 10,676 shares of Teva Pharmaceutical IndustriesSEC Form 46 March 2025Ordinary Shares · traded 4 March 2025 · filed 6 March 2025
- exercised options over 5,650 shares of Teva Pharmaceutical IndustriesSEC Form 46 March 2025Ordinary Shares · traded 4 March 2025 · filed 6 March 2025
- exercised options over 5,179 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 45 March 2025Restricted Share Units · traded 3 March 2025 · filed 5 March 2025
- exercised options over 5,179 shares of Teva Pharmaceutical IndustriesSEC Form 45 March 2025Ordinary Shares · traded 3 March 2025 · filed 5 March 2025
- ▼ sold on the open market 15,500 shares of Teva Pharmaceutical IndustriesSEC Form 417 May 2024Ordinary Shares · traded 15 May 2024 · filed 17 May 2024
- ▼ sold on the open market 12,635 shares of Teva Pharmaceutical IndustriesSEC Form 417 May 2024Ordinary Shares · traded 16 May 2024 · filed 17 May 2024
- exercised options over 3,564 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 47 March 2024Restricted Share Units · traded 5 March 2024 · filed 7 March 2024
- exercised options over 3,564 shares of Teva Pharmaceutical IndustriesSEC Form 47 March 2024Ordinary Shares · traded 5 March 2024 · filed 7 March 2024
- exercised options over 5,179 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 45 March 2024Restricted Share Units · traded 3 March 2024 · filed 5 March 2024
- exercised options over 10,676 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 45 March 2024Restricted Share Units · traded 4 March 2024 · filed 5 March 2024
- was granted 22,600 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 45 March 2024Restricted Share Units · traded 4 March 2024 · filed 5 March 2024
- exercised options over 5,179 shares of Teva Pharmaceutical IndustriesSEC Form 45 March 2024Ordinary Shares · traded 3 March 2024 · filed 5 March 2024
- exercised options over 10,676 shares of Teva Pharmaceutical IndustriesSEC Form 45 March 2024Ordinary Shares · traded 4 March 2024 · filed 5 March 2024
- exercised options over 3,219 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 41 March 2024Restricted Share Units · traded 28 February 2024 · filed 1 March 2024
- exercised options over 3,219 shares of Teva Pharmaceutical IndustriesSEC Form 41 March 2024Ordinary Shares · traded 28 February 2024 · filed 1 March 2024
- ▼ sold on the open market 31,766 shares of Teva Pharmaceutical IndustriesSEC Form 45 February 2024Ordinary Shares · traded 1 February 2024 · filed 5 February 2024
- ▼ sold on the open market 1,981 shares of Teva Pharmaceutical IndustriesSEC Form 47 August 2023Ordinary Shares · traded 4 August 2023 · filed 7 August 2023
- was granted 20,717 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 47 March 2023Restricted Share Units · traded 3 March 2023 · filed 7 March 2023
- exercised options over 2,406 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 47 March 2023Restricted Share Units · traded 4 March 2023 · filed 7 March 2023
- exercised options over 10,676 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 47 March 2023Restricted Share Units · traded 4 March 2023 · filed 7 March 2023
- exercised options over 3,564 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 47 March 2023Restricted Share Units · traded 5 March 2023 · filed 7 March 2023
- exercised options over 2,406 shares of Teva Pharmaceutical IndustriesSEC Form 47 March 2023Ordinary Shares · traded 4 March 2023 · filed 7 March 2023
- exercised options over 10,676 shares of Teva Pharmaceutical IndustriesSEC Form 47 March 2023Ordinary Shares · traded 4 March 2023 · filed 7 March 2023
- exercised options over 3,564 shares of Teva Pharmaceutical IndustriesSEC Form 47 March 2023Ordinary Shares · traded 5 March 2023 · filed 7 March 2023
- exercised options over 3,219 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 42 March 2023Restricted Share Units · traded 28 February 2023 · filed 2 March 2023
- exercised options over 3,219 shares of Teva Pharmaceutical IndustriesSEC Form 42 March 2023Ordinary Shares · traded 28 February 2023 · filed 2 March 2023
- exercised options over 2,403 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 48 March 2022Restricted Share Units · traded 4 March 2022 · filed 8 March 2022
- was granted 42,707 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 48 March 2022Restricted Share Units · traded 4 March 2022 · filed 8 March 2022
- exercised options over 3,564 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 48 March 2022Restricted Share Units · traded 5 March 2022 · filed 8 March 2022
- exercised options over 2,403 shares of Teva Pharmaceutical IndustriesSEC Form 48 March 2022Ordinary Shares · traded 4 March 2022 · filed 8 March 2022
- exercised options over 3,564 shares of Teva Pharmaceutical IndustriesSEC Form 48 March 2022Ordinary Shares · traded 5 March 2022 · filed 8 March 2022
- exercised options over 3,219 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 42 March 2022Restricted Share Units · traded 28 February 2022 · filed 2 March 2022
- exercised options over 981 shares of Teva Pharmaceutical Industries (a derivative holding)SEC Form 42 March 2022Restricted Share Units · traded 2 March 2022 · filed 2 March 2022
- exercised options over 3,219 shares of Teva Pharmaceutical IndustriesSEC Form 42 March 2022Ordinary Shares · traded 28 February 2022 · filed 2 March 2022
- exercised options over 981 shares of Teva Pharmaceutical IndustriesSEC Form 42 March 2022Ordinary Shares · traded 2 March 2022 · filed 2 March 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.